Meera Bajwa, MD
Nephrology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 25 years
- University of Michigan Medical School, 2001
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: 052526 · 552794 · Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bajwa’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A83248 · Current
Licensed to practise in California · since 2003 · expires 2026-10-31 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$141,833
Medicare paid this office $141,833 for 351 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $22,373 | $251 |
| Return visit (30+ min) | 144 | $22,177 | $102 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $21,593 | $304 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $15,889 | $65 |
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $12,445 | $175 |
See all 17 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $22,373 | $251 |
| Return visit (30+ min) | 144 | $22,177 | $102 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $21,593 | $304 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $15,889 | $65 |
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $12,445 | $175 |
| Long return visit (40+ min) | 41 | $10,145 | $156 |
| Telephone medical discussion with physician, 21-30 minutes | 40 | $5,450 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $5,185 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,103 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,710 | $107 |
| New patient visit (45+ min) | 27 | $3,794 | $141 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 12 | $2,571 | $6 |
| Short return visit (20+ min) | 26 | $2,115 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,324 | $83 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,158 | $41 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 24 | $422 | $14 |
| Injection of drug or substance under skin or into muscle | 12 | $418 | $13 |
Who their Medicare patients are
351 Original Medicare patients in 2024. Average age 77 · Under 65 10% · 85 and older 23% · Women 37% · Also on Medicaid 26% · Health risk score 3.60. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Coronary heart disease 52% · Diabetes 47% · Heart failure 43% · Atrial fibrillation 38% · Depression 28% · Cancer 23% · COPD 19% · Stroke 19% · Dementia 14%.
The office billed $801,619, Medicare allowed $184,272 and paid $141,833; for 1,620 services of 32 kinds; $2,571 of it was for drugs given in the office and $139,262 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 351 | 1,620 | 77 | 3.60 | $801,619 | $141,833 |
| 2023 | 345 | 1,248 | 77 | 3.71 | $481,770 | $136,584 |
| 2022 | 346 | 2,263 | 76 | 3.56 | $200,249 | $146,143 |
| 2021 | 306 | 1,718 | 75 | 3.72 | $201,982 | $154,474 |
| 2020 | 281 | 1,272 | 75 | 4.25 | $133,015 | $95,239 |
| 2019 | 269 | 820 | 73 | 4.22 | $96,723 | $45,326 |
| 2018 | 319 | 1,431 | 72 | 4.14 | $180,933 | $84,408 |
| 2017 | 329 | 1,193 | 73 | 3.97 | $184,031 | $84,231 |
| 2016 | 329 | 1,336 | 73 | 4.26 | $182,874 | $87,505 |
| 2015 | 322 | 1,491 | 73 | 3.84 | $180,814 | $87,340 |
| 2014 | 270 | 916 | 74 | 3.90 | $124,512 | $58,417 |
| 2013 | 235 | 707 | 73 | 4.05 | $84,436 | $42,849 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 42 | $23,743 | $308 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $21,713 | $69 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $20,799 | $257 |
| Return visit (30+ min) | 109 | $18,739 | $109 |
| Dialysis services, 1 physician visit per month (20 years or older) | 32 | $9,585 | $178 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $6,410 | $112 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $6,178 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,397 | $150 |
| New patient visit (45+ min) | 28 | $4,019 | $144 |
| Long return visit (40+ min) | 18 | $3,233 | $147 |
| Short return visit (20+ min) | 28 | $2,480 | $83 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 41 | $2,417 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,371 | $103 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,415 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,259 | $79 |
| Hemodialysis procedure with physician evaluation | 12 | $1,001 | $63 |
| Injection of drug or substance under skin or into muscle | 11 | $228 | $13 |
2022: 19 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 110 | $25,107 | $63 |
| Return visit (30+ min) | 114 | $22,564 | $114 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 33 | $19,683 | $323 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $19,347 | $269 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,000 | $175 |
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 21 | $6,769 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $6,211 | $119 |
| New patient visit (45+ min) | 39 | $5,709 | $146 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $5,590 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,350 | $91 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $4,201 | $111 |
| Long return visit (40+ min) | 13 | $2,866 | $169 |
| Hemodialysis procedure with physician evaluation | 20 | $2,326 | $65 |
| Short return visit (20+ min) | 22 | $1,792 | $81 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,406 | $83 |
| Advance care planning, first 30 minutes | 13 | $970 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $897 | $69 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $748 | $34 |
| Injection of drug or substance under skin or into muscle | 20 | $664 | $14 |
2021: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $39,666 | $328 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $26,431 | $65 |
| Return visit (30+ min) | 111 | $24,810 | $116 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $17,880 | $275 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $5,641 | $123 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $5,358 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,888 | $181 |
| New patient visit (45+ min) | 30 | $4,276 | $143 |
| Long return visit (40+ min) | 13 | $2,403 | $172 |
| Hemodialysis procedure with physician evaluation | 24 | $2,378 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $2,168 | $90 |
| Short return visit (20+ min) | 19 | $1,838 | $80 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,801 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,307 | $93 |
2020: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $37,873 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $12,377 | $66 |
| Return visit (30+ min) | 56 | $7,202 | $101 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $6,230 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,308 | $183 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,917 | $115 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 57 | $3,785 | $31 |
| New patient visit (45+ min) | 23 | $3,557 | $155 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $2,955 | $211 |
| Hemodialysis procedure with physician evaluation | 26 | $2,374 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,820 | $79 |
2019: 8 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 137 | $11,199 | $31 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $8,575 | $226 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $6,105 | $109 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 45 | $3,878 | $79 |
| Return visit (30+ min) | 45 | $3,074 | $61 |
| Hemodialysis procedure with physician evaluation | 27 | $2,576 | $59 |
| Short return visit (20+ min) | 29 | $1,510 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,433 | $57 |
2018: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 52 | $33,151 | $220 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 120 | $9,977 | $30 |
| Return visit (30+ min) | 71 | $6,862 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,364 | $104 |
| Short return visit (20+ min) | 79 | $4,217 | $47 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $4,188 | $78 |
| Hemodialysis procedure with physician evaluation | 26 | $2,384 | $57 |
| New patient visit (45+ min) | 21 | $2,291 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,951 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,586 | $57 |
2017: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $33,051 | $213 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 122 | $10,292 | $30 |
| Return visit (30+ min) | 97 | $9,189 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,055 | $101 |
| Hemodialysis procedure with physician evaluation | 37 | $3,766 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 44 | $3,501 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,873 | $55 |
| Short return visit (20+ min) | 49 | $2,681 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,374 | $148 |
| New patient visit (45+ min) | 17 | $1,737 | $102 |
2016: 12 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $25,114 | $185 |
| Return visit (30+ min) | 102 | $11,102 | $74 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 109 | $8,679 | $31 |
| Hemodialysis procedure with physician evaluation | 36 | $4,071 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 46 | $4,015 | $79 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $3,959 | $220 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,398 | $106 |
| New patient visit (45+ min) | 30 | $3,313 | $110 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $3,270 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,242 | $154 |
| Short return visit (20+ min) | 56 | $2,905 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,793 | $56 |
2015: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 56 | $28,285 | $185 |
| Return visit (30+ min) | 111 | $12,997 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 111 | $8,912 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $4,899 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $3,875 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,368 | $153 |
| New patient visit (45+ min) | 26 | $3,238 | $125 |
| Hemodialysis procedure with physician evaluation | 29 | $3,172 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,701 | $142 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,530 | $79 |
| Short return visit (20+ min) | 37 | $1,993 | $51 |
2014: 10 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 53 | $14,304 | $163 |
| Return visit (30+ min) | 96 | $13,102 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 77 | $4,973 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,694 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,197 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,162 | $55 |
| New patient visit (45+ min) | 20 | $2,066 | $103 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $1,716 | $132 |
| Hemodialysis procedure with physician evaluation | 17 | $1,472 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,415 | $79 |
2013: 10 services
| Return visit (30+ min) | 75 | $11,270 | $76 |
| Dialysis services, 1 physician visit per month (20 years or older) | 45 | $6,577 | $143 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 77 | $5,098 | $29 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,167 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,444 | $104 |
| Hemodialysis procedure with physician evaluation | 28 | $2,699 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,135 | $153 |
| New patient visit (45+ min) | 14 | $1,437 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,171 | $78 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,006 | $77 |
Medicaid work
$47,281 in 2024
Medicaid paid $47,281 for 175 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 71 | $18,745 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 41 | $15,284 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 63 | $13,252 |
| 2024 | 175 | 3 | 38 | $47,281 |
| 2023 | 514 | 4 | 31 | $77,713 |
| 2022 | 219 | 3 | 27 | $25,827 |
| 2021 | 533 | 4 | 24 | $33,032 |
| 2020 | 261 | 2 | 22 | $27,769 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 130 | $31,638 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 100 | $23,725 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 63 | $13,564 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 221 | $8,787 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 75 | $13,824 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 63 | $9,969 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $2,034 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 117 | $19,872 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 367 | $8,656 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 33 | $4,289 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 16 | $215 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 114 | $22,523 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 147 | $5,247 |
Drugs they prescribed that Part D paid
$241,706
Pharmacies billed $241,706 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 835) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
719 generic and 116 brand-name prescriptions · $241,706 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 28 | $93,240 | $3,330 |
| Farxiga | 19 | $28,327 | $1,491 |
| Lokelma | 13 | $23,007 | $1,770 |
| Kerendia | 19 | $21,991 | $1,157 |
| Veltassa | 13 | $21,922 | $1,686 |
See all 25 drugs
| Velphoro | 28 | $93,240 | $3,330 |
| Farxiga | 19 | $28,327 | $1,491 |
| Lokelma | 13 | $23,007 | $1,770 |
| Kerendia | 19 | $21,991 | $1,157 |
| Veltassa | 13 | $21,922 | $1,686 |
| Sevelamer Carbonate | 40 | $11,999 | $300 |
| Calcium Acetate | 22 | $2,420 | $110 |
| Nifedipine Er | 28 | $765 | $27 |
| Losartan | 77 | $744 | $10 |
| Bumetanide | 15 | $615 | $41 |
| Labetalol | 16 | $522 | $33 |
| Amlodipine Besylate | 64 | $451 | $7 |
| Tamsulosin | 27 | $362 | $13 |
| Rosuvastatin | 24 | $344 | $14 |
| Calcitriol | 34 | $341 | $10 |
| Hydralazine | 22 | $334 | $15 |
| Valsartan | 18 | $317 | $18 |
| Chlorthalidone | 18 | $316 | $18 |
| Furosemide | 40 | $305 | $8 |
| Carvedilol | 38 | $297 | $8 |
| Hydrochlorothiazide | 36 | $217 | $6 |
| Allopurinol | 12 | $177 | $15 |
| Atorvastatin | 20 | $158 | $8 |
| Lisinopril | 31 | $127 | $4 |
| Benazepril | 14 | $37 | $3 |
Year by year
| 2024 | 835 | 178 | 0% (0) | 14% | $241,706 |
| 2023 | 639 | 140 | 0% (0) | None | $187,581 |
| 2022 | 650 | 120 | 0% (0) | None | $221,184 |
| 2021 | 619 | 122 | 0% (0) | 20% | $125,933 |
| 2020 | 361 | 126 | 0% (0) | 11% | $22,574 |
| 2019 | 940 | 175 | 0% (0) | None | $67,824 |
| 2018 | 1,165 | 201 | None | None | $88,333 |
| 2017 | 1,185 | 210 | 0% (0) | None | $81,664 |
| 2016 | 1,348 | 233 | 0% (0) | 16% | $165,679 |
| 2015 | 1,068 | 193 | None | 17% | $113,392 |
| 2014 | 907 | 158 | None | None | $107,728 |
| 2013 | 693 | 114 | None | 21% | $34,364 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Farxiga | 31 | $40,744 | $1,314 |
| Veltassa | 26 | $34,456 | $1,325 |
| Lokelma | 11 | $17,572 | $1,597 |
| Sevelamer Carbonate | 20 | $10,777 | $539 |
| Losartan | 65 | $1,109 | $17 |
| Tamsulosin | 29 | $525 | $18 |
| Nifedipine Er | 11 | $521 | $47 |
| Amlodipine Besylate | 67 | $504 | $8 |
| Valsartan | 11 | $436 | $40 |
| Chlorthalidone | 25 | $366 | $15 |
| Calcitriol | 32 | $311 | $10 |
| Lisinopril | 33 | $285 | $9 |
| Allopurinol | 18 | $268 | $15 |
| Carvedilol | 16 | $227 | $14 |
| Furosemide | 32 | $202 | $6 |
| Atorvastatin | 11 | $180 | $16 |
2022: 21 drugs
| Renvela | 21 | $65,870 | $3,137 |
| Farxiga | 37 | $50,929 | $1,376 |
| Veltassa | 18 | $18,996 | $1,055 |
| Sevelamer Carbonate | 25 | $3,974 | $159 |
| Prosol | 32 | $3,786 | $118 |
| Potassium Citrate Er | 14 | $2,599 | $186 |
| Nifedipine Er | 14 | $995 | $71 |
| Valsartan | 21 | $948 | $45 |
| Calcitriol | 27 | $602 | $22 |
| Losartan | 47 | $552 | $12 |
| Allopurinol | 17 | $477 | $28 |
| Lisinopril | 31 | $404 | $13 |
| Furosemide | 39 | $371 | $10 |
| Amlodipine Besylate | 60 | $322 | $5 |
| Diltiazem 24hr Er (Cd) | 12 | $275 | $23 |
| Chlorthalidone | 12 | $269 | $22 |
| Tamsulosin | 15 | $248 | $17 |
| Carvedilol | 13 | $223 | $17 |
| Hydralazine | 13 | $216 | $17 |
| Atorvastatin | 13 | $106 | $8 |
| Diazepam | 11 | $69 | $6 |
2021: 16 drugs
| Renvela | 19 | $42,670 | $2,246 |
| Farxiga | 15 | $13,502 | $900 |
| Sevelamer Carbonate | 26 | $7,260 | $279 |
| Clinolipid | 31 | $5,817 | $188 |
| Calcium Acetate | 14 | $1,021 | $73 |
| Nifedipine Er | 11 | $688 | $63 |
| Tamsulosin | 24 | $651 | $27 |
| Losartan | 39 | $612 | $16 |
| Furosemide | 45 | $536 | $12 |
| Hydralazine | 18 | $499 | $28 |
| Amlodipine Besylate | 54 | $498 | $9 |
| Calcitriol | 21 | $491 | $23 |
| Metoprolol | 13 | $480 | $37 |
| Carvedilol | 19 | $285 | $15 |
| Atorvastatin | 11 | $156 | $14 |
| Lisinopril | 25 | $126 | $5 |
2020: 11 drugs
| Potassium Citrate Er | 12 | $1,831 | $153 |
| Losartan | 46 | $654 | $14 |
| Amlodipine Besylate | 28 | $381 | $14 |
| Potassium Chloride | 12 | $359 | $30 |
| Atorvastatin | 15 | $309 | $21 |
| Allopurinol | 16 | $261 | $16 |
| Hydralazine | 11 | $256 | $23 |
| Lisinopril | 23 | $218 | $9 |
| Furosemide | 35 | $145 | $4 |
| Carvedilol | 13 | $133 | $10 |
| Hydrochlorothiazide | 12 | $100 | $8 |
2019: 23 drugs
| Veltassa | 27 | $20,013 | $741 |
| Potassium Citrate Er | 32 | $10,362 | $324 |
| Bystolic | 12 | $4,921 | $410 |
| Losartan | 102 | $1,428 | $14 |
| Amlodipine Besylate | 103 | $1,352 | $13 |
| Diltiazem 24hr Er (Cd) | 33 | $1,323 | $40 |
| Bumetanide | 13 | $1,255 | $97 |
| Atorvastatin | 47 | $1,074 | $23 |
| Pravastatin | 41 | $811 | $20 |
| Labetalol | 15 | $716 | $48 |
| Allopurinol | 33 | $714 | $22 |
| Potassium Chloride | 25 | $670 | $27 |
| Lisinopril | 60 | $602 | $10 |
| Hydralazine | 17 | $525 | $31 |
| Terazosin | 11 | $505 | $46 |
| Spironolactone | 28 | $491 | $18 |
| Furosemide | 76 | $441 | $6 |
| Tamsulosin | 15 | $386 | $26 |
| Hydrochlorothiazide | 36 | $322 | $9 |
| Calcitriol | 19 | $318 | $17 |
| Torsemide | 12 | $252 | $21 |
| Omeprazole | 11 | $236 | $21 |
| Simvastatin | 16 | $119 | $7 |
2018: 30 drugs
| Veltassa | 24 | $16,273 | $678 |
| Auryxia | 11 | $13,663 | $1,242 |
| Potassium Citrate Er | 23 | $9,175 | $399 |
| Bystolic | 18 | $4,587 | $255 |
| Sevelamer Carbonate | 12 | $4,416 | $368 |
| Potassium Chloride | 38 | $1,817 | $48 |
| Amlodipine Besylate | 100 | $1,695 | $17 |
| Atorvastatin | 52 | $1,564 | $30 |
| Diltiazem 24hr Er (Cd) | 25 | $1,377 | $55 |
| Calcium Acetate | 20 | $1,224 | $61 |
| Losartan | 109 | $1,205 | $11 |
| Pravastatin | 44 | $1,047 | $24 |
| Allopurinol | 47 | $973 | $21 |
| Terazosin | 26 | $813 | $31 |
| Labetalol | 14 | $652 | $47 |
| Chlorthalidone | 13 | $642 | $49 |
| Cartia Xt | 17 | $636 | $37 |
| Hydrochlorothiazide | 57 | $628 | $11 |
| Hydralazine | 23 | $594 | $26 |
| Spironolactone | 32 | $572 | $18 |
| Calcitriol | 25 | $561 | $22 |
| Furosemide | 95 | $560 | $6 |
| Metolazone | 12 | $559 | $47 |
| Metoprolol | 15 | $521 | $35 |
| Lisinopril | 70 | $470 | $7 |
| Tamsulosin | 12 | $288 | $24 |
| Bisoprolol | 13 | $251 | $19 |
| Simvastatin | 22 | $243 | $11 |
| Carvedilol | 14 | $165 | $12 |
| Metoprolol | 15 | $116 | $8 |
2017: 25 drugs
| Potassium Citrate Er | 15 | $6,434 | $429 |
| Uloric | 13 | $5,082 | $391 |
| Diltiazem 24hr Er | 13 | $2,106 | $162 |
| Atorvastatin | 85 | $1,952 | $23 |
| Calcitriol | 44 | $1,565 | $36 |
| Losartan | 117 | $1,326 | $11 |
| Amlodipine Besylate | 99 | $1,280 | $13 |
| Calcium Acetate | 16 | $1,217 | $76 |
| Potassium Chloride | 28 | $1,119 | $40 |
| Chlorthalidone | 17 | $1,094 | $64 |
| Valsartan | 22 | $967 | $44 |
| Pravastatin | 33 | $891 | $27 |
| Allopurinol | 41 | $836 | $20 |
| Hydralazine | 22 | $834 | $38 |
| Cartia Xt | 22 | $768 | $35 |
| Terazosin | 35 | $724 | $21 |
| Hydrochlorothiazide | 69 | $628 | $9 |
| Lisinopril | 77 | $592 | $8 |
| Furosemide | 109 | $563 | $5 |
| Tamsulosin | 14 | $357 | $26 |
| Mirtazapine | 12 | $338 | $28 |
| Spironolactone | 22 | $311 | $14 |
| Simvastatin | 24 | $205 | $9 |
| Carvedilol | 17 | $189 | $11 |
| Metoprolol | 15 | $88 | $6 |
2016: 29 drugs
| Renvela | 36 | $76,814 | $2,134 |
| Sensipar | 14 | $20,643 | $1,475 |
| Calcium Acetate | 36 | $5,541 | $154 |
| Potassium Citrate Er | 20 | $4,970 | $249 |
| Uloric | 13 | $4,172 | $321 |
| Diltiazem 24hr Er | 16 | $2,579 | $161 |
| Calcitriol | 91 | $2,564 | $28 |
| Clonidine | 13 | $1,551 | $119 |
| Atorvastatin | 72 | $1,540 | $21 |
| Valsartan | 23 | $1,371 | $60 |
| Hydralazine | 54 | $1,337 | $25 |
| Amlodipine Besylate | 116 | $1,174 | $10 |
| Metolazone | 16 | $1,032 | $65 |
| Pravastatin | 45 | $983 | $22 |
| Allopurinol | 51 | $933 | $18 |
| Losartan | 70 | $839 | $12 |
| Potassium Chloride | 24 | $778 | $32 |
| Lisinopril | 80 | $709 | $9 |
| Furosemide | 150 | $678 | $5 |
| Tamsulosin | 21 | $654 | $31 |
| Cartia Xt | 12 | $598 | $50 |
| Fenofibrate | 12 | $567 | $47 |
| Terazosin | 26 | $420 | $16 |
| Spironolactone | 24 | $351 | $15 |
| Mirtazapine | 12 | $351 | $29 |
| Simvastatin | 33 | $320 | $10 |
| Hydrochlorothiazide | 64 | $313 | $5 |
| Carvedilol | 14 | $227 | $16 |
| Metoprolol | 11 | $87 | $8 |
2015: 25 drugs
| Renvela | 20 | $46,157 | $2,308 |
| Sensipar | 19 | $24,587 | $1,294 |
| Calcium Acetate | 35 | $5,687 | $162 |
| Uloric | 13 | $3,774 | $290 |
| Atorvastatin | 64 | $2,147 | $34 |
| Calcitriol | 55 | $2,011 | $37 |
| Pravastatin | 60 | $1,482 | $25 |
| Potassium Chloride | 26 | $1,441 | $55 |
| Valsartan | 19 | $1,364 | $72 |
| Fenofibrate | 13 | $1,126 | $87 |
| Allopurinol | 49 | $845 | $17 |
| Hydralazine | 34 | $804 | $24 |
| Furosemide | 101 | $628 | $6 |
| Labetalol | 15 | $525 | $35 |
| Amlodipine Besylate | 53 | $524 | $10 |
| Spironolactone | 33 | $520 | $16 |
| Chlorthalidone | 15 | $488 | $33 |
| Lisinopril | 75 | $476 | $6 |
| Losartan | 41 | $426 | $10 |
| Mirtazapine | 13 | $404 | $31 |
| Terazosin | 27 | $252 | $9 |
| Hydrochlorothiazide | 41 | $239 | $6 |
| Carvedilol | 15 | $149 | $10 |
| Simvastatin | 25 | $139 | $6 |
| Gabapentin | 14 | $108 | $8 |
2014: 23 drugs
| Renvela | 22 | $26,280 | $1,195 |
| Sensipar | 26 | $22,743 | $875 |
| Calcium Acetate | 28 | $7,857 | $281 |
| Potassium Citrate Er | 18 | $4,638 | $258 |
| Benicar | 13 | $2,019 | $155 |
| Calcitriol | 51 | $2,018 | $40 |
| Fenofibrate | 14 | $1,948 | $139 |
| Diltiazem 24hr Cd | 17 | $1,244 | $73 |
| Potassium Chloride | 27 | $1,219 | $45 |
| Pravastatin | 30 | $1,117 | $37 |
| Atorvastatin | 30 | $900 | $30 |
| Hydralazine | 37 | $808 | $22 |
| Amlodipine Besylate | 47 | $744 | $16 |
| Losartan | 27 | $549 | $20 |
| Furosemide | 74 | $368 | $5 |
| Simvastatin | 26 | $356 | $14 |
| Allopurinol | 42 | $353 | $8 |
| Spironolactone | 28 | $346 | $12 |
| Lisinopril | 33 | $275 | $8 |
| Carvedilol | 29 | $224 | $8 |
| Chlorthalidone | 14 | $195 | $14 |
| Hydrochlorothiazide | 23 | $173 | $8 |
| Terazosin | 18 | $130 | $7 |
2013: 25 drugs
| Uloric | 16 | $3,174 | $198 |
| Crestor | 12 | $2,059 | $172 |
| Diltiazem 24hr Er | 11 | $1,999 | $182 |
| Calcitriol | 53 | $1,922 | $36 |
| Fenofibrate | 13 | $1,763 | $136 |
| Benicar | 12 | $1,386 | $116 |
| Hydralazine | 36 | $839 | $23 |
| Atorvastatin | 29 | $790 | $27 |
| Losartan | 27 | $712 | $26 |
| Potassium Chloride | 15 | $657 | $44 |
| Amlodipine Besylate | 36 | $501 | $14 |
| Diltiazem 24hr Cd | 17 | $462 | $27 |
| Lisinopril | 49 | $433 | $9 |
| Nifedipine Er | 11 | $421 | $38 |
| Pravastatin | 25 | $370 | $15 |
| Allopurinol | 59 | $327 | $6 |
| Furosemide | 39 | $253 | $6 |
| Tamsulosin | 18 | $241 | $13 |
| Mirtazapine | 12 | $217 | $18 |
| Doxazosin Mesylate | 11 | $195 | $18 |
| Metoprolol | 21 | $147 | $7 |
| Chlorthalidone | 14 | $115 | $8 |
| Carvedilol | 11 | $97 | $9 |
| Hydrochlorothiazide | 13 | $70 | $5 |
| Bumetanide | 11 | $44 | $4 |
Money from drug and device companies
$188 in 2025
| 2025 | 3 | 4 | None | $188 |
| 2024 | 3 | 7 | None | $85 |
| 2023 | 4 | 8 | None | $179 |
| 2022 | 1 | 1 | None | $19 |
| 2021 | 1 | 1 | None | $21 |
| 2020 | 1 | 1 | None | $23 |
| 2019 | 3 | 3 | None | $49 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $117 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $41 | 2 payments
|
| Lilly USA | Jardiance | $31 | 1 payment
|
See all 4 published payments
| Lilly USA | Meals · 2025-06-05 | Jardiance | $31 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-17 | Kerendia | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-06 | Kerendia | $22 |
| Baxter Healthcare | Meals · 2025-01-29 | None | $117 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $85
| AstraZeneca Pharmaceuticals LP | Farxiga | $46 | 2 payments
|
| Lilly USA | Jardiance | $27 | 1 payment
|
| Travere Therapeutics | None | $12 | 4 payments
|
2023: $179
| AstraZeneca Pharmaceuticals LP | Lokelma | $115 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $27 | 1 payment
|
| Travere Therapeutics | None | $23 | 4 payments
|
| Calliditas Therapeutics US | Tarpeyo | $14 | 1 payment
|
2022: $19
| Amgen | Tavneos | $19 | 1 payment
|
2021: $21
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
2020: $23
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
2019: $49
| Genentech USA | Rituxan | $19 | 1 payment
|
| Relypsa | Veltassa | $15 | 1 payment
|
| NxStage Medical | System One | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1639357841
- Licence
- CA A83248California A83248: Current · expires 2026-10-31
- Trained
- University of Michigan Medical School, 2001 · 25 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 501 Howard Ave, Ste D 204, Altoona, PA, 16601
- NPI first listed
- 2008-02-11
- NPI last updated
- 2012-05-10
This is when the NPI record was last certified, not a medical board exam.